Drugs / AFFITOPE® PD03A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02267434 | Dec 2014 → Aug 2016 | Parkinson disease, neurodegenerative disease | Affiris AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AFFITOPE PD03A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02267434 ↗ |
| Modality | Vaccine | “the vaccine AFFITOPE® PD03A” NCT02267434 ↗ |
| Route | Subcutaneous | “s.c. injection” NCT02267434 ↗ |